Join us for the 4th year of this important conference, where international leaders in the field will discuss the importance of effective cancer control in low and middle-income countries (LMIC) and highlight the magnitude of the disparities and issues that currently exist. This event is part of the inaugural London Global Cancer Week – a series of coordinated international discussions and events that provides a comprehensive image of the growing incidence of cancer worldwide, encourages countries to prioritise cancer control services in their health strategies, and discusses how the UK can contribute towards building capacity for sustainable cancer control in developing countries through training, research, aid, and diplomacy.At the RSM meeting, first-hand accounts of healthcare professionals working in low and middle income countries will share experiences to increase awareness on global cancer collaborations that currently exist, improve understanding of the challenges to delivering cancer care, and provide a forum to discuss future strategies to improve global cancer control. Topics include:- Build collaborative networks between LMIC, UK and globally- Address the global disparity in cancer care through collaborative networks- Promote learning and sharing through practice and data-sharing across the globe- Advocate for improvement in global cancer control and learn how to become further involved in this field- Create a global grassroots network for cancer control in LMIC- Provide an opportunity for attendees to showcase their work in this fieldKey international healthcare organisations including THET and Kings Health Partners will be represented. Call for abstracts: Vanessa Moss annual prizePrize: Winner of best abstract – £250 and invited for oral presentation; Top 10 abstracts – poster presentationSubmission deadline: 1st August 2019Eligibility Criteria:1. Any scientist or healthcare professional working in the field of global cancer control may apply2. Collaborative research / service delivery in which the applicant has been significantly involved, in global cancer control, focusing on LMICs (as defined by world bank group)3. The project may be clinical or scientific4. Work may have been published previously (but not before 2018)Abstract guidelines:400 words maximum, including background, methods, results and discussion.Submissions open to HICs and LMICs. The judging panel will include oncologists and experts in the field of global cancer care who will consider the originality and the impact of the research on the quality of care for patients with cancer in LMICs, within the context of the resources available to the host institution.The winner must agree to attend the conference.For further information and to submit, please contact